These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 31918944)

  • 21. 2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.
    Xu B; Saito Y; Baumbach A; Kelbæk H; van Royen N; Zheng M; Morel MA; Knaapen P; Slagboom T; Johnson TW; Vlachojannis G; Arkenbout KE; Holmvang L; Janssens L; Ochala A; Brugaletta S; Naber CK; Anderson R; Rittger H; Berti S; Barbato E; Toth GG; Maillard L; Valina C; Buszman P; Thiele H; Schächinger V; Lansky A; Wijns W;
    JACC Cardiovasc Interv; 2019 Sep; 12(17):1679-1687. PubMed ID: 31129092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients.
    Zhang Y; Farooq V; Garcia-Garcia HM; Bourantas CV; Tian N; Dong S; Li M; Yang S; Serruys PW; Chen SL
    EuroIntervention; 2012 Nov; 8(7):855-65. PubMed ID: 23171805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).
    Vlachojannis GJ; Smits PC; Hofma SH; Togni M; Vázquez N; Valdés M; Voudris V; Slagboom T; Goy JJ; den Heijer P; van der Ent M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1215-1221. PubMed ID: 28579236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
    Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C;
    JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention.
    Yamamoto K; Shiomi H; Morimoto T; Miyazawa A; Watanabe H; Natsuaki M; Watanabe H; Yamaji K; Ohya M; Nakamura S; Mitomo S; Suwa S; Domei T; Tatsushima S; Ono K; Sakamoto H; Shimamura K; Shigetoshi M; Taniguchi R; Nishimoto Y; Okayama H; Matsuda K; Yokomatsu T; Muto M; Kawaguchi R; Kishi K; Hadase M; Fujita T; Nishida Y; Nishino M; Otake H; Suematsu N; Ajimi T; Tanabe K; Abe M; Hibi K; Kadota K; Ando K; Kimura T;
    Circ Cardiovasc Interv; 2023 May; 16(5):e012922. PubMed ID: 37192307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials.
    Mahmoud AN; Barakat AF; Elgendy AY; Schneibel E; Mentias A; Abuzaid A; Elgendy IY
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28468954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: Results from ULTIMATE trial.
    Zhang J; Gao X; Ge Z; Han L; Lu S; Qian X; Li Q; Lu Q; Chen C; Chen SL;
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1184-1193. PubMed ID: 31116913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procedural Characteristics of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention and Their Clinical Implications.
    Lee SY; Zhang JJ; Mintz GS; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Kan J; Pan T; Gao X; Ge Z; Chen SL; Hong MK
    J Am Heart Assoc; 2022 Jul; 11(14):e025258. PubMed ID: 35861828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of everolimus-eluting stent length on long-term clinical outcomes of percutaneous coronary intervention.
    Yano H; Horinaka S; Ishimitsu T
    J Cardiol; 2018 May; 71(5):444-451. PubMed ID: 29174595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravascular Ultrasound Guidance Is Associated With Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared With Angiography Guidance Alone.
    Andell P; Karlsson S; Mohammad MA; Götberg M; James S; Jensen J; Fröbert O; Angerås O; Nilsson J; Omerovic E; Lagerqvist B; Persson J; Koul S; Erlinge D
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes in real-world patients with bifurcation lesions receiving Xience V everolimus-eluting stents: Four-year results from the Xience V USA study.
    Hermiller JB; Applegate RJ; Baird C; Butler MM; Rutledge D; Wang J; Kakarala K; Krucoff MW; Sudhir K
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):62-70. PubMed ID: 26399687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial.
    Shiomi H; Kozuma K; Morimoto T; Kadota K; Tanabe K; Morino Y; Akasaka T; Abe M; Takeji Y; Suwa S; Ito Y; Kobayashi M; Dai K; Nakao K; Tarutani Y; Taniguchi R; Nishikawa H; Yamamoto Y; Nakagawa Y; Ando K; Kobayashi K; Kawai K; Hibi K; Kimura T;
    JACC Cardiovasc Interv; 2019 Apr; 12(7):637-647. PubMed ID: 30947938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
    Maeng M; Baranauskas A; Christiansen EH; Kaltoft A; Holm NR; Krusell LR; Ravkilde J; Tilsted HH; Thayssen P; Jensen LO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1161-7. PubMed ID: 25640050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients.
    Buccheri S; Franchina G; Romano S; Puglisi S; Venuti G; D'Arrigo P; Francaviglia B; Scalia M; Condorelli A; Barbanti M; Capranzano P; Tamburino C; Capodanno D
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2488-2498. PubMed ID: 29153502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents.
    Kereiakes DJ; Windecker S; Jobe RL; Mehta SR; Sarembock IJ; Feldman RL; Stein B; Dubois C; Grady T; Saito S; Kimura T; Underwood P; Allocco DJ; Meredith IT
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008152. PubMed ID: 31451014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study.
    Witzenbichler B; Maehara A; Weisz G; Neumann FJ; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Stuckey TD; Mazzaferri EL; Xu K; Parise H; Mehran R; Mintz GS; Stone GW
    Circulation; 2014 Jan; 129(4):463-70. PubMed ID: 24281330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.